ADVERTISEMENT
ADVERTISEMENT
3D medical illustration showing acute lymphoblastic leukemia cells and red blood cells in circulation.
Niche Interactions Lock Down Leukemia Cells
Deanna MacNeil, PhD | Sep 24, 2023 | 3 min read
Researchers unravel the mystery of epithelial to mesenchymal transition in acute lymphoblastic leukemia with co-culture techniques, CRISPR-screening, and RNA sequencing.
Epigenetic Marks May Cause Brain Tumor Formation
Jennifer Zieba, PhD | Sep 19, 2023 | 3 min read
Scientists established an epigenetic mouse model for glioma, providing insight into how epigenetics can initiate cancer.
New Strategies for Cancer Immunotherapy
New Strategies for Cancer Immunotherapy
The Scientist’s Creative Services Team | 2 min read
An expert panel will discuss the interplay between cancer and the immune system, and how researchers develop immunotherapies and other immune-supporting strategies against cancer. 
The Breakthrough Prize ?Trophy
2024 Breakthrough Prizes in Life Sciences
Danielle Gerhard, PhD | Sep 14, 2023 | 10 min read
This year’s Breakthrough Prizes honor advances in CAR T cancer therapies, cystic fibrosis, and Parkinson’s disease.
Carolyn Bertozzi working in the laboratory with postdoctoral scholar Ula Gerling-Driessen
Trimming Undruggable Cancer Targets
Deanna MacNeil, PhD | Sep 13, 2023 | 4 min read
Researchers took aim at mucins, glycoproteins that protect cancer cells from drugs and the immune response, and engineered a revolutionary targeted tool for oncology and beyond.
Cancer Vaccines: A Dose of Prevention
Cancer Vaccines: A Dose of Prevention
The Scientist’s Creative Services Team | 1 min read
Discover the latest progress behind therapeutic vaccines that boost the immune system’s cancer-killing abilities.
Close up on eyes of mother and daughter faces next to one another
A Long and Unhealthy Life?
Aparna Nathan, PhD | Sep 13, 2023 | 3 min read
A new mouse model shows that the Myc protein has complex effects on aging and cancer.
Image of spatial transcriptomic spots superimposed onto a stained tissue section.
Poor Cancer Prognosis Associated with a Transcriptional Signature
Charlene Lancaster, PhD | Sep 11, 2023 | 4 min read
Researchers connect a tumor’s leading edge transcriptional profile to poor survival outcomes across cancer types. 
Automating Circulating Tumor Cell Isolation and Transfer
Automating Circulating Tumor Cell Isolation and Transfer
The Scientist’s Creative Services Team | 1 min read
Darius Cameron Wilson will discuss how the latest automated cell isolation technology streamlines circulating tumor cell applications. 
Colorful blue and pink low poly side view human brain illustration with connection dots isolated on bright blue background
Cancer Cells Need Fatty Acids to Survive in the Brain
Danielle Gerhard, PhD, Drug Discovery News | Aug 30, 2023 | 3 min read
Using a mouse model of breast cancer brain metastasis, researchers showed that tumor cells require fatty acid synthesis to grow, which offers a potential therapeutic target.
A drawing of the sun on the sand, surrounded by items that people use to protect themselves from UV damage, including sunscreen, a hat, and sunglasses.
Taking Snapshots of DNA Damage in Skin Cancer
Deanna MacNeil, PhD | Aug 15, 2023 | 3 min read
Researchers turn to high resolution sequencing to explain recurrent melanoma mutations caused by UV exposure.
Transforming Molecular Tools into Precision Oncology
Transforming Molecular Tools into Precision Oncology
The Scientist’s Creative Services Team | 1 min read
Learn how researchers establish new technologies such as liquid biopsies and targeted biomarker detection to further enhance precision oncology.
Medical illustration of brain cancer with a microscopic magnification of malignant cells dividing in the tumor microenvironment.
Capturing the Brain Tumor Microenvironment with Tissue Engineering
Deanna MacNeil, PhD | Aug 4, 2023 | 3 min read
Researchers built a 3D glioblastoma model to study therapeutic resistance and improve drug screening systems.
T cell antigen binding site
Multiple Targets, Infinite Possibilities
The Scientist Staff | Aug 1, 2023 | 2 min read
Multispecific antibodies are rising stars in the field of antibody therapeutics, offering better specificity, targeting ability, and therapeutic effects than traditional monoclonal antibodies.
<em >The Scientist</em>&rsquo;s Journal Club: Cancer
The Scientist’s Journal Club: Cancer
The Scientist’s Creative Services Team | 1 min read
Scientists present the latest research on immune cell responses to cancer, the role of epigenetics in cancer, and molecular imaging of the tumor microenvironment.
Tumor microenvironment concept with cancer cells
Cancers Protect Themselves Against Their Own Mutations
Ida Emilie Steinmark, PhD | Aug 1, 2023 | 2 min read
Tumors overexpress certain genes to survive a growing pile of harmful mutations, a trait that scientists could exploit to target with drugs.
Digital illustration of AI concept
How should we proceed with image-analyzing AI?
Ida Emilie Steinmark, PhD | Aug 1, 2023 | 2 min read
Algorithms can now glean ever more molecular and genetic information from images of stained tissue, but some researchers worry that we can’t follow their logic.
Abstract rendering of a tumor and its microenvironment in purple
The Basics of the Tumor Microenvironment
Johanna Pruller, PhD | 4 min read
Learn about the tumor microenvironment (TME), a key influencer of cancer growth, spread, and treatment success.
iStock
Death by Stem Cell: Developing New Cancer Therapies
Charlene Lancaster, PhD | Jul 24, 2023 | 3 min read
Khalid Shah engineers stem cells to deliver cancer therapeutics directly to tumors, thereby increasing their efficacy.
3D rendered medical illustration of T cells trying to subdue cancer cells.
How Tumors Tire Out T Cells
PhenomeX | Jul 19, 2023 | 1 min read
Researchers investigated how cancer antigenicity drives unique forms of T cell exhaustion and hypofunctionality.
ADVERTISEMENT